The largest database of trusted experimental protocols

Three way perfusion valve controller

Manufactured by Harvard Apparatus
Sourced in United States

The Three-way Perfusion Valve Controller is a laboratory instrument designed to control the flow of fluids in a perfusion system. It allows for the precise regulation of three independent fluid channels, enabling the user to switch between different solutions or compounds during an experiment. The device provides a compact and reliable interface for managing the flow of liquids in a controlled and reproducible manner.

Automatically generated - may contain errors

2 protocols using three way perfusion valve controller

1

Whole-cell Patch-clamp Recordings of Voltage-dependent Ion Currents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-cell patch-clamp recordings were performed in −60 mV clamped-cells by using the following solutions: extracellular (mM): HEPES 10, D-glucose 5, NaCl 140, KCl 3, MgCl2 2, and CaCl2 2 (pH 7.4). Pipette (mM): K-Aspartate 130, MgCl2 2, Na2-ATP 5, Na2-GTP 0.1, EGTA 11, HEPES 10 (pH 7.2). Data were acquired with an Axopatch 200B amplifier (Axon Instruments, Union City, CA, USA), low-pass filtered at 10 kHz, stored and analyzed with a pClamp 9.2 software (Axon Instruments). Detailed protocols used to evoke voltage-dependent K+ or Na+ currents are described in Supplementary Material. Drugs used were applied by superfusion with a three-way perfusion valve controller (Harvard Apparatus). Current-clamp recordings were performed by applying 12 steps of current injection (300 ms duration; 100 pA increment, from −100 pA to 1000 pA) from the resting membrane potential of the investigated cell, as already described (Coppi et al., 2012 (link)) and detailed in Supplementary Material.
+ Open protocol
+ Expand
2

Preparing Pharmacological Agents for Electrophysiology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dexpramipexole (DEX), tetraethylammonium (TEA), (±)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2methoxybenzamide (sulpiride), apamin, 4-amynopyridine (4-AP), and ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′tetraacetic acid (EGTA) were obtained from Sigma-Aldrich (http://www.sigmaaldrich.com). All drugs were dissolved in distilled water, stored at -20 °C as 10 3 to 10 4 times more concentrated stock solutions, and dissolved daily in the extracellular solution to the final concentration and applied by bath superfusion with a three-way perfusion valve controller (Harvard Apparatus, Holliston, MA USA) after a stable baseline of ramp-evoked currents was obtained. A complete exchange of bath solution in the recording chamber was achieved within 28 s.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!